医学
达帕格列嗪
心脏病学
射血分数
内科学
血压
临床终点
冲程容积
心力衰竭
肺动脉高压
糖尿病
随机对照试验
2型糖尿病
内分泌学
作者
Hiroyuki Kayano,Shinji Koba,Tsutomu Hirano,Taiju Matsui,Hiroto Fukuoka,Hiroaki Tsuijita,Shigeto Tsukamoto,Toshiyuki Hayashi,Tsutomu Toshida,Norikazu Watanabe,Yuji Hamazaki,Eiichi Geshi,Mikitaka Murakami,Kazuo Aihara,Koujin Kaneko,Hirokazu Yamada,Youichi Kobayashi,Toshiro Shinke
出处
期刊:Circulation journal
[The Japanese Circulation Society]
日期:2020-09-11
卷期号:84 (10): 1807-1817
被引量:59
标识
DOI:10.1253/circj.cj-20-0341
摘要
Dapagliflozin significantly improved RVSP and LVFP during exercise in patients with T2DM and cardiovascular risk, which may contribute to favorable effects on heart failure.
科研通智能强力驱动
Strongly Powered by AbleSci AI